debutylbupivacaine 100 mg | Purity Not Available
TargetMol
Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier Page
Debutylbupivacaine is the intermediate of ropivacaine hydrochloride and bupivacaine.
More Information Supplier Page
Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.
More Information Supplier Page
Azasetron Hydrochloride is a 5-HT3 receptor antagonist which is used as an anti-emetic.
More Information Supplier Page
Mitiglinide calcium hydrate (S-21403 calcium hydrate) is a drug for the treatment of type 2 diabetes. Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) K(ATP) channels in pancreatic beta-cells. Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda.
More Information Supplier Page
Darifenacin hydrobromide (UK-88525) is a selective muscarinic receptor antagonist used to treat urinary incontinence and overactive bladder syndrome.
More Information Supplier Page
Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.
More Information Supplier Page
Drospirenone is a synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity.
More Information Supplier Page
Raloxifene hydrochloride is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
More Information Supplier Page
Raloxifene hydrochloride is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
More Information Supplier Page
Tigecycline is a broad-spectrum glycylcycline antibiotic derived from tetracycline. Tigecycline binds to the 30S ribosomal subunit, thereby interfering with the binding of aminoacyl-tRNA to the mRNA-ribosome complex.
More Information Supplier Page